Finally, we developed dual Aurora and JAK2 inhibitors that demonstrated potent inhibition of Aurora A, Aurora B and JAK2 in intact human cancer cells, induction of G2/M cell cycle accumulation and apoptosis as well as inhibition of anchorage-dependent and –independent proliferation, invasion and tumor growth in vivo. Here, JAK2 is linked to neoplasm.